EDESA BIOTECH, INC. Cash and Cash Equivalents
EDESA BIOTECH, INC. (EDSA) had Cash and Cash Equivalents of $10.30 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $10.30M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $10.00M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $12.10M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $10.80M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $10.30M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.00M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $12.10M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $10.80M 10-K · filed 2025-12-12 | |
| 2025-06-30 | $12.40M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $13.90M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.60M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $1.00M 10-K · filed 2024-12-13 | |
| 2023-09-30 | $5.40M 10-K · filed 2023-12-15 | |
| 2023-06-30 | $6.46M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.47M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $8.27M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $7.09M 10-Q · filed 2023-08-09 | |
| 2022-06-30 | $12.81M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $15.89M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $5.88M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $7.84M 10-K · filed 2022-12-16 | |
| 2021-06-30 | $8.05M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $10.97M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $6.31M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $7.21M 10-Q · filed 2022-08-12 | |
| 2020-06-30 | $5.64M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $6.99M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $3.83M 10-Q · filed 2021-02-16 | |
| 2019-09-30 | $5.03M 10-K · filed 2021-12-28 | |
| 2019-06-30 | $6.36M 10-Q · filed 2020-08-12 | |
| 2019-03-31 | $3.04M 10-Q · filed 2020-05-15 | $7.68M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.37M 10-K · filed 2020-12-07 | $7.36M 10-Q · filed 2019-02-05 |
| 2018-09-30 | $3.73M 10-Q · filed 2020-08-12 | $4.23M 10-K · filed 2018-11-30 |
| 2018-06-30 | $5.82M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $3.29M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $5.00M 10-KT · filed 2019-12-12 | $4.37M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $4.57M 10-Q · filed 2019-05-08 | |
| 2017-06-30 | $3.65M 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $4.60M 10-Q · filed 2018-05-07 | |
| 2016-12-31 | $5.89M 10-Q · filed 2018-02-07 | |
| 2016-09-30 | $7.42M 10-K · filed 2018-11-30 | |
| 2016-06-30 | $4.79M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $5.96M 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $3.89M 10-Q · filed 2017-02-06 | |
| 2015-09-30 | $3.96M 10-K · filed 2017-12-01 | |
| 2015-06-30 | $5.15M 10-Q · filed 2016-08-09 | $10.16M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $6.14M 10-Q · filed 2016-05-09 | $11.15M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $7.76M 10-Q · filed 2016-02-08 | $12.76M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $8.77M 10-K · filed 2017-12-01 | $13.77M 10-Q · filed 2015-02-09 |
| 2014-08-31 | $8.42M 10-K · filed 2016-12-14 | $13.43M 10-K · filed 2014-11-21 |
| 2014-06-30 | $14.44M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $15.42M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $16.73M 10-Q · filed 2015-02-09 | |
| 2013-09-30 | $15.48M 10-Q · filed 2015-08-10 | |
| 2013-08-31 | $7.86M 10-K · filed 2016-12-14 | |
| 2012-08-31 | $999.00K 10-K · filed 2015-12-14 | |
| 2011-08-31 | $4.15M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |